Authored Content
Clinicians can support timely, sustainable rare disease care through institutionalized multi-disciplinary roles, strengthened referral networks, and the translation of clinical insights into policy and advocacy.
Rare disease patient groups in APAC can amplify their impact through multi-stakeholder collaboration to achieve equitable access for people living with rare diseases.
In this first installment of our APAC rare disease series, we introduce the topic of multi-stakeholder collaboration and present a corresponding framework.